Vyas Tungaturti is a seasoned M&A operator and advisor specializing in large-scale mergers, acquisitions, and private equity due diligence. His experience spans integration and divestiture office leadership, complex cross-border transactions, and the application of AI and machine learning to deal execution. Founder of CorpDev.Org and builder of Kai, an AI due-diligence platform for deal teams, Vyas writes on deal intelligence, value creation, and how AI is reshaping M&A and PE workflows.
Franklin Templeton's $87 billion alternative credit AUM expansion through its Apera acquisition signals a calculated push into Europe's underserved lower mid-market . This transaction – expected...
The Delaware court-supervised auction of Citgo Petroleum's parent company has intensified with TPG Angelo Gordon's late-stage $3.7+ billion topping bid, creating a pivotal moment in the decade-long...
The proposed $9.4 billion acquisition of Skechers USA by 3G Capital – poised to become the largest footwear industry buyout – now faces mounting legal and strategic challenges. A shareholder...
German chemical conglomerate BASF has ignited one of 2025's most consequential corporate carve-outs with its €6 billion coatings division sale, attracting intense interest from private equity...
As traditional lenders retreat from commercial real estate, KKR has amassed a record $42 billion private credit pipeline – the largest in its history – positioning itself as the lender of last...
As global capital flows recalibrate post-pandemic, Apollo Global Management has emerged as the most aggressive foreign investor in Germany's corporate landscape. The $800 billion alternative asset...
French beauty conglomerate L'Oréal stands poised to finalize one of 2025's most significant beauty acquisitions with its €1 billion purchase of UK clinical skincare pioneer Medik8 . This...
Advanced Micro Devices (AMD) has intensified its challenge to Nvidia's AI dominance with the acquisition of compiler startup Brium, marking the sixth strategic purchase in its two-year campaign to...
The Delaware Court of Chancery's January 2022 decision in Wei v. Zoox, Inc. represents a pivotal moment in corporate governance jurisprudence, balancing shareholder rights with protections against...
In a landmark move with national implications, Oregon lawmakers passed Senate Bill 951 on May 28, 2025, enacting the most comprehensive state-level restrictions on corporate control of medical...
